Incrementality Test Delivered the Proof
Paxie ran a PSA-based incrementality test to measure the true impact of their retargeting ads. 80% of users were served branded retargeting ads, while 20% saw neutral charity Public Service Announcement ads instead. Bidding, targeting, and attribution logic were identical across both groups.

Using a statistical method called Agresti-Coull, Paxie measured the results with confidence. The numbers were clear: +118% incremental revenue from payers, +25% from non-payers, and +44% incremental revenue overall. ROAS target achieved.

The test didn’t just validate their retargeting success. It gave Paxie the confidence to scale.

‍

Geo Expansion Driven by Real Signals
The U.S. campaign set the benchmark. From there, Paxie expanded with tailored IAA and IAP campaigns across 
high-potential markets like the United Kingdom, France, 
Germany, Canada, Australia, Japan, and Austria.

‍

Investing in a Long-Term
RT Partner
After testing multiple platforms, Paxie chose RZR for the strongest results and strategic fit. They increased retargeting spend by 50%, scaled globally, and made RZR their exclusive partner.